Neridronate in the treatment of thalassemia-induced osteoporosis

被引：0
|
作者：
不详
机构：
来源：
CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [1] Bisphosphonates in the Treatment of Thalassemia-Induced Osteoporosis
    N. Morabito
    A. Lasco
    A. Gaudio
    A. Crisafulli
    C. Di Pietro
    A. Meo
    N. Frisina
    Osteoporosis International, 2002, 13 : 644 - 649
  • [2] Bisphosphonates in the treatment of thalassemia-induced osteoporosis
    Morabito, N
    Lasco, A
    Gaudio, A
    Crisafulli, A
    Di Pietro, C
    Meo, A
    Frisina, N
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 (08) : 644 - 649
  • [3] Study on intravenous zoledronic acid treatment in thalassemia-induced osteoporosis.
    Otrock, Z
    Azar, S
    Inati, A
    Koussa, S
    Mahfouz, R
    Taher, A
    BLOOD, 2004, 104 (11) : 27B - 27B
  • [4] Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis
    Pennisi, P
    Pizzarelli, G
    Spina, M
    Riccobene, S
    Fiore, CE
    JOURNAL OF BONE AND MINERAL METABOLISM, 2003, 21 (06) : 402 - 408
  • [5] Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis
    Pietra Pennisi
    Giuseppe Pizzarelli
    Massimo Spina
    Stefania Riccobene
    Carmelo Erio Fiore
    Journal of Bone and Mineral Metabolism, 2003, 21 : 402 - 408
  • [6] Taurine deficiency in thalassemia major-induced osteoporosis treated with neridronate
    D'Eufemia, P.
    Finocchiaro, R.
    Celli, M.
    Raccio, I.
    Zambrano, A.
    Tetti, M.
    Smacchia, P.
    Iacobini, M.
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (04) : 271 - 274
  • [7] Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial
    Zaher K. Otrock
    Sami T. Azar
    Wael A. Shamseddeen
    Dany Habr
    Adlette Inati
    Suzane Koussa
    Rami A. R. Mahfouz
    Ali T. Taher
    Annals of Hematology, 2006, 85 : 605 - 609
  • [8] Intravenous zoledronic acid treatment in thalassemia-induced osteoporosis: results of a phase II clinical trial
    Otrock, Zaher K.
    Azar, Sami T.
    Shamseddeen, Wacl A.
    Habr, Dany
    Inati, Adlette
    Koussa, Suzane
    Mahfouz, Rami A. R.
    Taber, Ali T.
    ANNALS OF HEMATOLOGY, 2006, 85 (09) : 605 - 609
  • [9] Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle
    Morabito, N
    Gaudio, A
    Lasco, A
    Atteritano, M
    Pizzoleo, MA
    Cincotta, M
    La Rosa, M
    Guarino, R
    Meo, A
    Frisina, N
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (05) : 722 - 727
  • [10] Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis
    Punzo, Francesca
    Tortora, Chiara
    Argenziano, Maura
    Casale, Maddalena
    Perrotta, Silverio
    Rossi, Francesca
    PLOS ONE, 2018, 13 (12):
12345